Peroxidase to Cytochrome b Type Transition in the Active Site of Heme-Bound Amyloid β Peptides Relevant to Alzheimer's Disease

Inorganic Chemistry
Chandradeep GhoshSomdatta Ghosh Dey

Abstract

Recent evidence has established the colocalization of amyloid-rich plaques and heme-rich deposits in the human cerebral cortex as a common postmortem feature in Alzheimer's disease (AD). The amyloid β (Aβ) peptides have been shown to bind heme, and the resultant heme-Aβ complexes can generate toxic partially reduced oxygen species (PROS) and exhibit peroxidase activity. The heme-Aβ active site exhibits a concentration-dependent equilibrium between a high-spin mono-His-bound species similar to a peroxidase-type active site and a bis-His-bound six-coordinate low-spin species similar to that of a cytochrome b type active site. The ν(Fe-His) (241 cm(-1)) vibration has been identified in the high-spin heme-Aβ active site by resonance Raman spectroscopy. The formation of the low-spin heme-Aβ species is promoted by the His14 and noncoordinating second-sphere Arg5 residues. The high-spin state produces more PROS than the low-spin species. Nonbiological constructs modeling different forms of Aβ (oligomers, fibrils, etc.) suggest that the detrimental high-spin state is likely to dominate under most physiological conditions.

References

Dec 1, 1974·Archives of Biochemistry and Biophysics·F Adar, M Erecińska
Aug 16, 1984·Biochemical and Biophysical Research Communications·G G Glenner, C W Wong
May 16, 1984·Biochemical and Biophysical Research Communications·G G Glenner, C W Wong
Feb 17, 1981·Biochemistry·P M Callahan, G T Babcock
Jun 1, 1995·Annals of Neurology·H M SchipperE G Stopa
Dec 27, 1994·Biochemistry·G SmulevichK G Welinder
Nov 1, 1993·Journal of Neurochemistry·C Vigo-PelfreyD B Schenk
Mar 25, 1998·Analytical Chemistry·D Beauchemin, R Kisilevsky
Jul 17, 1998·Journal of the Neurological Sciences·M A LovellW R Markesbery
Aug 7, 1999·The Journal of Biological Chemistry·R A ChernyA I Bush
Oct 12, 2000·Nature·T BurmesterT Hankeln
Oct 18, 2000·FEBS Letters·J Nunan, D H Small
Mar 20, 2002·The Journal of Biological Chemistry·Sarah J FieldDavid J Richardson
Mar 29, 2002·Chembiochem : a European Journal of Chemical Biology·Cristina RedaelliLucia Banci
Oct 26, 2002·Science·Dennis J Selkoe
Oct 23, 2003·The Journal of Biological Chemistry·Peter M SchmidtJohannes-Peter Stasch
Mar 24, 2004·Micron : the International Research and Review Journal for Microscopy·Alessandra PesceMartino Bolognesi
May 19, 2004·Journal of Neurochemistry·Feng LiGunnar K Gouras
Jul 21, 2004·Proceedings of the National Academy of Sciences of the United States of America·Hani Atamna, William H Frey
Jul 28, 2004·Biochemistry·Manabu IshidaYasuhiro Isogai
Aug 10, 2004·Biophysical Journal·Luca TofaniGiulietta Smulevich
Sep 4, 2004·Antioxidants & Redox Signaling·Shigeru Sassa
May 27, 2005·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Karen M CullenJonathan Stone

❮ Previous
Next ❯

Citations

Jul 7, 2017·Dalton Transactions : an International Journal of Inorganic Chemistry·Soumya MukherjeeSomdatta Ghosh Dey
Jun 7, 2018·The Journal of Biological Chemistry·Sitara B SankarLevi B Wood
Apr 17, 2020·Chemical Communications : Chem Comm·Madhuparna RoySomdatta Ghosh Dey

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

© 2021 Meta ULC. All rights reserved